A. Verma
Cancer Research · with Forbes · 2002
A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 3 researchers here, as inferred from the citation graph.
Subfields
- Cancer Research — 11 citations into it; #1,021 of 1,780 by trust here, #1,310 by citations
Whom A. Verma trusts
Their strongest outbound trust, strongest first, inferred from their citations.
- G. Semenza (in Cancer Research)
Who trusts A. Verma
- S. Orrenius (in Molecular Biology)
- V. Gogvadze (in Molecular Biology)
- B. Zhivotovsky (in Molecular Biology)
Papers from A. Verma's perspective
Ordered by how strongly the researchers A. Verma trusts endorse each paper. Same corpus, a different order for every researcher.
- Targeting of HIF-α to the von Hippel-Lindau Ubiquitylation Complex by O2-Regulated Prolyl Hydroxylation (Science)
- Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha. (Genes & Development)
- Hypoxia — a key regulatory factor in tumour growth (Nature Reviews. Cancer)
- Hypoxia Inducible Factor-α Binding and Ubiquitylation by the von Hippel-Lindau Tumor Suppressor Protein* (Journal of Biological Chemistry)
- Why do cancers have high aerobic glycolysis? (Nature Reviews. Cancer)
- Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. (Journal of Clinical Investigation)
- The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth (Nature)
- HIF-1: mediator of physiological and pathophysiological responses to hypoxia. (Journal of applied physiology)
- Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein. (Cancer Cell)
- Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1. (Cancer Research)